P

Inventor

MORISHITA RYUICHI

JP48 patents
⚠️ This page may combine multiple inventors who share the name “MORISHITA RYUICHI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ANGES MG INC

15 patents
US7285540B2Oct 23, 2007

Medicament comprising HGF gene

ANGES MG INC20 citations90
US6989374B1Jan 24, 2006

Gene therapy for cardiomyopathy

ANGES MG INC11 citations82
US7595301B2Sep 29, 2009

Staple type oligonucleotide and drug comprising the same

ANGES MG INC12 citations78
US6936594B1Aug 30, 2005

Gene therapy for cerebrovascular disorders

ANGES MG INC8 citations72
US7247620B2Jul 24, 2007

Method of treating skin wounds with vectors encoding hepatocyte growth factor

ANGES MG INC6 citations70
US7763591B2Jul 27, 2010

Hepatocyte growth factor gene therapy for parkinson's disease

ANGES MG INC4 citations63
US7871983B2Jan 18, 2011

Remedy and preventive for diseases caused by NF-κB

ANGES MG INC2 citations60
US7504098B2Mar 17, 2009

Method for introducing a biological molecule using a viral envelope and heparin and system therefore

ANGES MG INC2 citations60
US7259149B2Aug 21, 2007

Methods for treating or preventing angiogenesis-dependent symptoms

ANGES MG INC2 citations58
US7390482B2Jun 24, 2008

Drug for auditory dysfunction

ANGES MG INC1 citations52
US9889186B2Feb 13, 2018

Oral vaccine having improved cellular immunity induction potency

ANGES MG INC0 citations49
US7939504B2May 10, 2011

Method of treating skin ulcers with vectors encoding hepatocyte growth factor

ANGES MG INC0 citations49
US7524830B2Apr 28, 2009

Decoy-containing pharmaceutical compositions and method of using the same

ANGES MG INC1 citations48
US7994151B2Aug 9, 2011

Compositions and methods for angiogenic therapy utilizing genes encoding ets-1

ANGES MG INC1 citations45
US7790692B2Sep 7, 2010

Hepatocyte growth factor nucleic acid sequence to enhance musculocutaneous flap survival

ANGES MG INC0 citations42

UNIV OSAKA

14 patents
US10112978B2Oct 30, 2018

Peptide and use thereof

UNIV OSAKA4 citations72
US9872825B2Jan 23, 2018

Peptide with anti-aging effect and use thereof

UNIV OSAKA4 citations71
US10517926B2Dec 31, 2019

Oligopeptide having proinflammatory cytokine secretion-inhibiting activity

UNIV OSAKA3 citations66
US11421025B2Aug 23, 2022

Treatment of IL-17A diseases

UNIV OSAKA0 citations62
US12070498B2Aug 27, 2024

Conjugate vaccine targeting a disease-causing biological protein

UNIV OSAKA0 citations61
US10980876B2Apr 20, 2021

Conjugate vaccine targeting a disease-causing biological protein

UNIV OSAKA1 citations61
US11819537B2Nov 21, 2023

Preventive or therapeutic method for inflammatory skin disease

UNIV OSAKA1 citations59
US10543261B2Jan 28, 2020

DNA vaccine containing VEGF-specific epitope and/or angiopoietin-2-specific epitope

UNIV OSAKA1 citations59
US11020464B2Jun 1, 2021

Immunogenic composition targeting S100A9

UNIV OSAKA0 citations58
US11583221B2Feb 21, 2023

Cognitive impairment diagnostic apparatus and cognitive impairment diagnostic program

UNIV OSAKA0 citations51
US10233215B2Mar 19, 2019

Peptide and use thereof

UNIV OSAKA0 citations51
US10463592B2Nov 5, 2019

Peptide with anti-aging effect and use thereof

UNIV OSAKA0 citations50
US12227743B2Feb 18, 2025

Pharmaceutical composition for treatment of diseases associated with upregulated periostin expression or periostin splice variant switching

UNIV OSAKA0 citations45
US10227396B2Mar 12, 2019

Antibody against peptide encoded by Exon-21 of periostin and pharmaceutical composition for preventing or treating inflammation-associated diseases containing the same

UNIV OSAKA0 citations43

MORISHITA RYUICHI

5 patents

ANGES INC

3 patents

BRIGHAM & WOMENS HOSPITAL

2 patents

DAIICHI SANKYO CO LTD

2 patents

GEMBA TAKEFUMI

2 patents

ASUBIO PHARMA CO LTD

1 patent

FUJISAWA PHARMACEUTICAL CO

1 patent

MEDGENE BIOSCIENCE INC

1 patent

LEE IN-KYU

1 patent

FUNPEP INC

1 patent